Gruppo Oncologico Italiano Di Ricerca Clinica
Clinical trials sponsored by Gruppo Oncologico Italiano Di Ricerca Clinica, explained in plain language.
-
Italian study maps rare HER2 mutations in advanced lung cancer
Knowledge-focused Recruiting nowThis study looks at how often HER2 gene changes occur in people with advanced non-small cell lung cancer (NSCLC) in Italy, and how doctors currently treat these cases. About 50 adults with advanced NSCLC will be observed for one year. The goal is to gather information, not to tes…
Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica • Aim: Knowledge-focused
Last updated May 17, 2026 03:01 UTC
-
Scientists investigate why osimertinib stops working in lung cancer
Knowledge-focused Recruiting nowThis study is for people with a specific type of lung cancer (EGFR-mutated NSCLC) whose cancer came back during or after treatment with the drug osimertinib. Researchers will analyze tumor and blood samples to find new genetic changes that may explain why the cancer returned. The…
Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica • Aim: Knowledge-focused
Last updated May 17, 2026 02:55 UTC